Loading clinical trials...

Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy | Clinical Trials | Clareo Health

WITHDRAWNPhase 1NCT00505583

Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy

To evaluate the effects of single oral doses of MOA-728 compared to a positive control in subjects on methadone therapy.

Lead sponsor: Bausch Health Americas, Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 1

Study Evaluating MOA-728 in Subjects on Stable Methadone Maintenance

NCT00447811 · Methadone-maintenance Subjects

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 29, 2019Terms

Trial snapshot

StatusWITHDRAWN

PhasePHASE1

Enrollment—

Start dateJul 2007

Last updatedNov 29, 2019

Condition

Methadone-maintenance Subjects

Locations shown

Gainesville, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 29, 2019Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions